US Capital Partners Inc. has advised on a $10 million credit facility for MusclePharm Corporation (“MusclePharm”), an award-winning American nutritional supplement company headquartered in Denver, Colorado. MusclePharm is sold in over 120 countries and available in over 45,000 global retail outlets.
US Capital Partners is a private investment bank that makes direct debt investments, participates in debt facilities, and has robust distribution for debt and equity private placements for lower middle market businesses. The firm’s creative and dynamic approach has helped it grow quickly into a leading investment bank in its sector.
“We are delighted to have advised on the refinancing of this market-leader in the sports nutrition industry,” said Jeffrey Sweeney, Chairman and CEO at US Capital Partners. “MusclePharm approached us to refinance existing debt and to provide additional working capital to support its ongoing growth. US Capital Partners was able to analyze MusclePharm’s assets, and then to structure and provide a non-traditional, flexible $10 million accounts receivable and inventory line of credit to meet MusclePharm’s unique needs.”
Headed by former professional athletes, MusclePharm is a global lifestyle enterprise that manufactures, markets, and distributes branded nutritional products and supplements. With more than 15 industry awards, including “Brand of the Year,” MusclePharm is dedicated to developing and bringing to market clinically proven, safe and effective nutritional and sports supplementation products to enhance athletic performance, strength, and overall personal health—all without the use of banned substances.